These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 17261417

  • 21. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.
    Allen JA, Adlakha A, Bergethon PR.
    Arch Neurol; 2006 Oct; 63(10):1475-8. PubMed ID: 17030665
    [Abstract] [Full Text] [Related]

  • 22. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
    Yamada R, Okawa T, Matsuo K, Suzuki M, Mori N, Mori K.
    BMC Nephrol; 2019 Jan 11; 20(1):14. PubMed ID: 30634936
    [Abstract] [Full Text] [Related]

  • 23. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.
    Yahata M, Nakaya I, Sakuma T, Sato H, Aoki S, Soma J.
    BMC Res Notes; 2013 Nov 09; 6():450. PubMed ID: 24207130
    [Abstract] [Full Text] [Related]

  • 24. Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening.
    Simpkins F, Belinson JL, Rose PG.
    Gynecol Oncol; 2007 Oct 09; 107(1):118-23. PubMed ID: 17658587
    [Abstract] [Full Text] [Related]

  • 25. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
    Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D'Agati VD.
    Nephrol Dial Transplant; 2005 Jul 09; 20(7):1400-6. PubMed ID: 15840673
    [Abstract] [Full Text] [Related]

  • 26. Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer.
    Krämer I, Lipp HP.
    J Clin Pharm Ther; 2007 Feb 09; 32(1):1-14. PubMed ID: 17286784
    [Abstract] [Full Text] [Related]

  • 27. Reversible membranous glomerulonephritis associated with ketoprofen.
    Sennesael J, Van den Houte K, Verbeelen D.
    Clin Nephrol; 1986 Oct 09; 26(4):213-5. PubMed ID: 3780072
    [Abstract] [Full Text] [Related]

  • 28. Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab.
    Levy CF, Oo KZ, Fireman F, Pierre L, Bania MA, Sadanandan S, Yamashiro DJ, Glade Bender JL.
    Pediatr Blood Cancer; 2009 May 09; 52(5):669-71. PubMed ID: 19101996
    [Abstract] [Full Text] [Related]

  • 29. Emerging safety data for bevacizumab in advanced non-small-cell lung cancer.
    Hirsh V.
    Clin Lung Cancer; 2008 Mar 09; 9 Suppl 2():S62-70. PubMed ID: 21885001
    [Abstract] [Full Text] [Related]

  • 30. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.
    Chase JL.
    Pharmacotherapy; 2008 Nov 09; 28(11 Pt 2):23S-30S. PubMed ID: 18980549
    [Abstract] [Full Text] [Related]

  • 31. Proteinuria and nephrotic syndrome induced by renin in patients with renal artery stenosis.
    Kumar A, Shapiro AP.
    Arch Intern Med; 1980 Dec 09; 140(12):1631-4. PubMed ID: 7006541
    [Abstract] [Full Text] [Related]

  • 32. FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.
    Cohen MH, Gootenberg J, Keegan P, Pazdur R.
    Oncologist; 2007 Jun 09; 12(6):713-8. PubMed ID: 17602060
    [Abstract] [Full Text] [Related]

  • 33. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.
    Zhu X, Wu S, Dahut WL, Parikh CR.
    Am J Kidney Dis; 2007 Feb 09; 49(2):186-93. PubMed ID: 17261421
    [Abstract] [Full Text] [Related]

  • 34. Kimura disease: a case report and review of the Chinese literature.
    Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, Liu AM.
    Nephron Clin Pract; 2009 Feb 09; 111(1):c55-61. PubMed ID: 19052471
    [Abstract] [Full Text] [Related]

  • 35. Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac.
    Révai T, Harmos G.
    Wien Klin Wochenschr; 1999 Jul 09; 111(13):523-4. PubMed ID: 10444806
    [Abstract] [Full Text] [Related]

  • 36. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K, Iskandar SS, Daeihagh P, Ratliff HL, Bleyer AJ.
    Nephrol Dial Transplant; 2008 May 09; 23(5):1595-9. PubMed ID: 18065791
    [Abstract] [Full Text] [Related]

  • 37. [Nephrotic Syndrome Induced by Ramucirumab for Metastatic Rectal Cancer].
    Sakabe R, Shirakawa K, Yoshimura K, Otsuka H, Kuwada A, Tahara K, Hotei H, Maeda Y.
    Gan To Kagaku Ryoho; 2018 Aug 09; 45(8):1205-1207. PubMed ID: 30158421
    [Abstract] [Full Text] [Related]

  • 38. [Severe nephrotic syndrome with reversible acute kidney failure in lupus-associated membranous nephropathy].
    Pauli-Magnus C, Mettang T, Kuhlmann U.
    Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):788-92. PubMed ID: 10414228
    [Abstract] [Full Text] [Related]

  • 39. Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy.
    Burkart CM, Grisel JJ, Hom DB.
    Laryngoscope; 2008 Sep 25; 118(9):1539-41. PubMed ID: 18622319
    [Abstract] [Full Text] [Related]

  • 40. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.
    Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, Kabbinavar F, Novotny W, Sarkar S, Hurwitz H.
    J Surg Oncol; 2005 Sep 01; 91(3):173-80. PubMed ID: 16118771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.